News from REMEDY

New research project on biological medicines:

“This will be a national boost. We hope that we will conduct a study that can change clinical practice,” says project manager Silje Watterdal Syversen at the REMEDY Center.

Ingvild Kjeken speaks in this webinar about patient education and lifestyle changes, based on insights that emerged from this year's EULAR conference in Vienna, in June 2024. 

Cand. Med. Ingrid Egeland Christensen has recently completed her doctorate at Diakonhjemmet Hospital and the research center REMEDY. Her thesis, Serious infections in patients with inflammatory joint diseases, highlights the increased risk of serious infections in patients treated with biological drugs.

In the second quarter of this year, we have received 37 media reports. Here is a little more information about some of them. The overview of those found is in the table at the bottom of this issue. You will also find links to the cases that it was possible to link to. 

Don't miss this year's hashtag #MUSS , the national research conference for musculoskeletal health!

Today, all patients with rheumatoid arthritis receive the same dose of biologic drugs. Now, researchers are investigating whether individually tailored doses will allow more people to benefit from the medications.

A recent study from researchers at Diakonhjemmet Hospital shows that almost half of the physiotherapists in primary health care who responded to the survey use digital health technology (DHT) in the treatment of musculoskeletal disorders.

Do you want to travel abroad to participate in a relevant research group? Read more here: